Home / Fact sheets / Sweden / Cervical quantitative data
Country fact sheet: Sweden (Index year: )
Age group | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 | 75-79 | Age unknown | Total |
Interval | ||||||||||||||
Screening interval (months) | 36 | 36 | 36 | 36 | 36 | 36 | 60 | 60 | 60 | 0 | 0 | 0 | 0 | |
Population (personally invited) | ||||||||||||||
Target population | 325579 | 297206 | 289250 | 303087 | 316197 | 332451 | 290908 | 286711 | 292974 | 0 | 0 | 0 | 0 | 2 734 363 |
Annual target population | 108 526 | 99 068 | 96 416 | 101 029 | 105 399 | 110 817 | 58 181 | 57 342 | 58 594 | 0 | 0 | 0 | 0 | 795 372 |
Women invited | 86185 | 142908 | 123489 | 123182 | 127763 | 134393 | 99721 | 86296 | 40719 | 0 | 0 | 0 | 8 | 964 664 |
Invitation coverage (%) | 79.4 | 144.3 | 128.1 | 121.9 | 121.2 | 121.3 | 171.4 | 150.5 | 69.5 | 0.0 | 0.0 | 0.0 | 0.0 | 121.3 |
Examinations | ||||||||||||||
Women screened | 46 849 | 68 248 | 63 114 | 68 786 | 72 345 | 74 974 | 50 846 | 43 357 | 20 145 | 0 | 0 | 0 | 6 | 508 670 |
Examination coverage rate (%) | 54.4 | 47.8 | 51.1 | 55.8 | 56.6 | 55.8 | 51.0 | 50.2 | 49.5 | 0.0 | 0.0 | 0.0 | 75.0 | 52.7 |
Result (A subset of tests) | ||||||||||||||
Subset women screened | 40 412 | 59 468 | 56 590 | 62 016 | 63 512 | 65 366 | 43 154 | 38 384 | 19 054 | 0 | 0 | 0 | 21 | 447 977 |
Positive | 4 944 | 5 101 | 3 215 | 2 613 | 2 379 | 2 195 | 1 212 | 773 | 345 | 0 | 0 | 0 | 3 | 22 780 |
Negative | 35 468 | 54 367 | 53 375 | 59 403 | 61 133 | 63 171 | 41 942 | 37 611 | 18 709 | 0 | 0 | 0 | 18 | 425 197 |
Unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Referral for further assessment (%) | 12.2 | 8.6 | 5.7 | 4.2 | 3.7 | 3.4 | 2.8 | 2.0 | 1.8 | 0.0 | 0.0 | 0.0 | 14.3 | 5.1 |
Further assessment (all positive) | ||||||||||||||
Done | 3 650 | 3 867 | 2 334 | 1 637 | 1 331 | 1 112 | 586 | 373 | 148 | 0 | 0 | 0 | 0 | 15 038 |
Not done | 1 294 | 1 234 | 881 | 976 | 1 048 | 1 083 | 626 | 400 | 197 | 0 | 0 | 0 | 3 | 7 742 |
Unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Further assessment participation rate (%) | 73.8 | 75.8 | 72.6 | 62.6 | 55.9 | 50.7 | 48.3 | 48.3 | 42.9 | 0.0 | 0.0 | 0.0 | 0.0 | 66.0 |
Outcome (CIN 1, CIN 2 and CIN 3 separetely) | ||||||||||||||
No biopsy performed, no CIN nor ca detected | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No biopsy performed, treated on the basis of colpo diagnosis of CIN (see and treat) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unsatisfactory histology | 41 | 45 | 28 | 23 | 19 | 22 | 25 | 24 | 11 | 0 | 0 | 0 | 0 | 238 |
Carcinoma | 4 | 21 | 24 | 24 | 24 | 10 | 10 | 12 | 8 | 0 | 0 | 0 | 0 | 137 |
CIN3 / Adenocarcinoma in situ (CGIN) | 358 | 662 | 502 | 318 | 228 | 154 | 60 | 42 | 21 | 0 | 0 | 0 | 0 | 2 345 |
CIN2 | 476 | 492 | 274 | 196 | 147 | 118 | 56 | 23 | 13 | 0 | 0 | 0 | 0 | 1 795 |
CIN1 | 669 | 646 | 314 | 208 | 194 | 161 | 83 | 50 | 18 | 0 | 0 | 0 | 0 | 2 343 |
Other histology | 194 | 224 | 116 | 89 | 63 | 82 | 46 | 35 | 11 | 0 | 0 | 0 | 0 | 860 |
Unknown | 1 908 | 1 777 | 1 076 | 779 | 656 | 565 | 306 | 187 | 66 | 0 | 0 | 0 | 0 | 7 320 |